Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase

References

• Aanouz, I., Belhassan, A., El Khatabi, K., Lakhlifi, T., El Idrissi, M., & Bouachrine, M. (2020). Moroccan medicinal plants as inhibitors of COVID-19: Computational investigations. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/10.1080/07391102.2020.1758790
   PubMed Web of Science ®Google Scholar
• Aggarwal, M., Leser, G. P., & Lamb, R. A. (2020). Repurposing papaverine as an antiviral agent against influenza viruses and paramyxoviruses. Journal of Virology, 94(6), 1–14. https://doi.org/10.1128/JVI.01888-19
   Web of Science ®Google Scholar
• Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., Ray, A. S., Cihlar, T., Siegel, D., Mackman, R. L., Clarke, M. O., Baric, R. S., & Denison, M. R. (2018). Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio, 9(2), 218. https://doi.org/10.1128/mBio.00221-18
   Web of Science ®Google Scholar
• Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020). Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses, 12(3), 254. https://doi.org/10.3390/v12030254
   PubMed Web of Science ®Google Scholar
• Andersen, P. I., Ianevski, A., Lysvand, H., Vitkauskiene, A., Oksenych, V., Bjørås, M., Telling, K., Lutsar, I., Dumpis, U., Irie, Y., Tenson, T., Kantele, A., & Kainov, D. E. (2020). Discovery and development of safe-in-man broad-spectrum antiviral agents. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 93, 268–276. https://doi.org/10.1016/j.ijid.2020.02.018
   PubMed Web of Science ®Google Scholar
• Arabi, Y. M., Alothman, A., Balkhy, H. H., Al-Dawood, A., AlJohani, S., Al Harbi, S., Kojan, S., Al Jeraisy, M., Deeb, A. M., Assiri, A. M., Al-Hameed, F., AlSaedi, A., Mandourah, Y., Almekhlafi, G. A., Sherbeeni, N. M., Elzein, F. E., Memon, J., Taha, Y., Almotairi, A., Maghrabi, K. A., Qushmaq, I., & Hussein, M. A. (2018). Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): Study protocol for a randomized controlled trial. Trials, 19(1), 81. https://doi.org/10.1186/s13063-017-2427-0
   PubMedGoogle Scholar
• Batlle, D., Wysocki, J., & Satchell, K. (2020). Soluble angiotensin-converting enzyme 2: A potential approach for coronavirus infection therapy? Clinical Science, 134(5), 543–545. https://doi.org/10.1042/CS20200163
   PubMed Web of Science ®Google Scholar
• Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 Coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/10.1080/07391102.2020.1758788
   PubMed Web of Science ®Google Scholar
• Brown, A. J., Won, J. J., Graham, R. L., Dinnon III, K. H., Sims, A. C., Feng, J. Y., Cihlar, T., Denison, M. R., Baric, R. S., & Sheahan, T. P. (2019). Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Research, 169, 104541. https://doi.org/10.1016/j.antiviral.2019.104541
   PubMed Web of Science ®Google Scholar
• Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19). In StatPearls [Internet]. StatPearls Publishing.
   Google Scholar
• Chatterjee, S. (2020). Understanding the nature of variations in structural sequences coding for coronavirus spike, envelope, membrane and nucleocapsid proteins of SARS-CoV-2, 1–12.
   Google Scholar
• Chen, L., & Hao, G. (2020). The role of angiotensin converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease. Cardiovascular Research. https://dx.doi.org/10.2139/ssrn.3537961
   Web of Science ®Google Scholar
• Chen, W.-H., Strych, U., Hotez, P. J., & Bottazzi, M. E. (2020). The SARS-CoV-2 vaccine pipeline: An overview. Current Tropical Medicine Reports. https://doi.org/10.1007/s40475-020-00201-6.
   PubMedGoogle Scholar
• Chhikara, B. S., Rathi, B., Singh, J., & Poonam, F. (2020). Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics. Chemical Biology Letters, 7, 63–72.
   Google Scholar
• Choi, W. S., Kang, C.-I., Kim, Y., Choi, J.-P., Joh, J. S., Shin, H.-S., Kim, G., Peck, K. R., Chung, D. R., Kim, H. O., Song, S. H., Kim, Y. R., Sohn, K. M., Jung, Y., Bang, J. H., Kim, N. J., Lee, K. S., Jeong, H. W., Rhee, J.-Y., Kim, E. S., Woo, H., & Kim, Y.-S. (2016). Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea. Infection & Chemotherapy, 48(2), 118–126. https://doi.org/10.3947/ic.2016.48.2.118
   PubMed Web of Science ®Google Scholar
• Cui, H., Zhang, C., Zhao, Z., Zhang, C., Fu, Y., Li, J., Chen, G., Lai, M., Li, Z., Dong, S., Chen, L., Li, Z., Wang, C., Liu, J., Gao, Y., & Guo, Z. (2020). Identification of cellular microRNA miR-188-3p with broad-spectrum anti-influenza A virus activity. Virology Journal, 17(1), 12. https://doi.org/10.1186/s12985-020-1283-9
   PubMed Web of Science ®Google Scholar
• de Wit, E., Feldmann, F., Cronin, J., Jordan, R., Okumura, A., Thomas, T., Scott, D., Cihlar, T., & Feldmann, H. (2020). Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proceedings of the National Academy of Sciences of the United States of America, 117(12), 6771–6776. https://doi.org/10.1073/pnas.1922083117
   PubMed Web of Science ®Google Scholar
• Dong, E., Du, H., & Gardner, L. (2020). An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases, 20(5), 533–534. https://doi.org/10.1016/S1473-3099(20)30120-1
   PubMed Web of Science ®Google Scholar
• Douglas, M. G., Kocher, J. F., Scobey, T., Baric, R. S., & Cockrell, A. S. (2018). Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease. Virology, 517, 98–107. https://doi.org/10.1016/j.virol.2017.12.006
   PubMed Web of Science ®Google Scholar
• Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/10.1080/07391102.2020.1758791
   PubMed Web of Science ®Google Scholar
• Enayatkhani, M., Hasaniazad, M., Faezi, S., Guklani, H., Davoodian, P., Ahmadi, N., Einakian, M. A., Karmostaji, A., & Ahmadi, K. (2020). Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An in silico study. Journal of Biomolecular Structure and Dynamics, 1–19. https://doi.org/10.1080/07391102.2020.1756411
   PubMed Web of Science ®Google Scholar
• Fang, L., Karakiulakis, G., & Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine, 8(4), e21. https://doi.org/10.1016/S2213-2600(20)30116-8
   PubMed Web of Science ®Google Scholar
• Fung, S.-Y., Yuen, K.-S., Ye, Z.-W., Chan, C.-P., & Jin, D.-Y. (2020). A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: Lessons from other pathogenic viruses. Emerging Microbes & Infections, 9(1), 558–570. https://doi.org/10.1080/22221751.2020.1736644
   PubMed Web of Science ®Google Scholar
• Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., Zhang, Y.-J., Luo, C.-M., Tan, B., Wang, N., Zhu, Y., Crameri, G., Zhang, S.-Y., Wang, L.-F., Daszak, P., & Shi, Z.-L. (2013). Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature, 503(7477), 535–538. https://doi.org/10.1038/nature12711
   PubMed Web of Science ®Google Scholar
• Gordon, C. J., Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Gotte, M. (2020). The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. The Journal of Biological Chemistry, 295(15), 4773–4779. https://doi.org/10.1074/jbc.AC120.013056
   PubMed Web of Science ®Google Scholar
• Gretebeck, L. M., & Subbarao, K. (2015). Animal models for SARS and MERS coronaviruses. Current Opinion in Virology, 13, 123–129. https://doi.org/10.1016/j.coviro.2015.06.009
   PubMed Web of Science ®Google Scholar
• Guo, D. (2020). Old weapon for new enemy: Drug repurposing for treatment of newly emerging viral diseases. Virologica Sinica, 1–3. https://doi.org/10.1007/s12250-020-00204-7
   PubMed Web of Science ®Google Scholar
• Guo, Y.-R., Cao, Q.-D., Hong, Z.-S., Tan, Y.-Y., Chen, S.-D., Jin, H.-J., Tan, K.-S., Wang, D.-Y., & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research, 7(1), 11. https://doi.org/10.1186/s40779-020-00240-0
   PubMed Web of Science ®Google Scholar
• Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, 1–17. https://doi.org/10.1080/07391102.2020.1751300
   PubMed Web of Science ®Google Scholar
• Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., & Mehrabi, M. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1754293
   PubMed Web of Science ®Google Scholar
• Heymann, D. L., & Shindo, N. (2020). COVID-19: What is next for public health? The Lancet, 395(10224), 542–545. https://doi.org/10.1016/S0140-6736(20)30374-3
   PubMed Web of Science ®Google Scholar
• Ianevski, A., Zusinaite, E., Kuivanen, S., Strand, M., Lysvand, H., Teppor, M., Kakkola, L., Paavilainen, H., Laajala, M., Kallio-Kokko, H., Valkonen, M., Kantele, A., Telling, K., Lutsar, I., Letjuka, P., Metelitsa, N., Oksenych, V., Bjørås, M., Nordbø, S. A., … Kainov, D. (2018). Novel activities of safe-in-human broad-spectrum antiviral agents. Antiviral Research, 154, 174–182. https://doi.org/10.1016/j.antiviral.2018.04.016
   PubMed Web of Science ®Google Scholar
• Ji, X., & Li, Z. (2020). Medicinal chemistry strategies toward host targeting antiviral agents. Medicinal Research Reviews, 1–39. https://doi.org/10.1002/med.21664
   Google Scholar
• Jordan, P. C., Liu, C., Raynaud, P., Lo, M. K., Spiropoulou, C. F., Symons, J. A., Beigelman, L., & Deval, J. (2018). Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase. PLoS Pathogens, 14(2), e1006889. https://doi.org/10.1371/journal.ppat.1006889
   PubMed Web of Science ®Google Scholar
• Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease$. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/10.1080/07391102.2020.1760137
   Web of Science ®Google Scholar
• Ju, J., Li, X., Kumar, S., Jockusch, S., Chien, M., Tao, C., Morozova, I., Kalachikov, S., Kirchdoerfer, R., & Russo, J. J. (2020). Nucleotide analogues as inhibitors of SARS-CoV polymerase. bioRxiv, 1–18. https://doi.org/10.1101/2020.03.12.989186
   Google Scholar
• Khan, R. J., Jha, R. K., Amera, G., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-Cov-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like Proteinase and 2’-O-RiboseMethyltransferase. Journal of Biomolecular Structure and Dynamics, 1–40. https://doi.org/10.1080/07391102.2020.1753577
   Web of Science ®Google Scholar
• Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1751298
   Web of Science ®Google Scholar
• Kouznetsova, J., Sun, W., Martínez-Romero, C., Tawa, G., Shinn, P., Chen, C. Z., Schimmer, A., Sanderson, P., McKew, J. C., Zheng, W., & García-Sastre, A. (2014). Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerging Microbes & Infections, 3(1), 1–7. https://doi.org/10.1038/emi.2014.88
   PubMed Web of Science ®Google Scholar
• Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International Journal of Antimicrobial Agents, 55(3), 105924. https://doi.org/10.1016/j.ijantimicag.2020.105924
   PubMed Web of Science ®Google Scholar
• Lai, M. M., & Cavanagh, D. (1997). The molecular biology of coronaviruses. In Advances in virus research (pp. 1–100). Elsevier.
   Google Scholar
• Li, G., & De Clercq, E. (2020). Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Publishing Group.
   Google Scholar
• Liu, Y., Gayle, A. A., Wilder-Smith, A., & Rocklöv, J. (2020). The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of Travel Medicine, 27(2), 1–4. https://doi.org/10.1093/jtm/taaa021
   Web of Science ®Google Scholar
• Lo, M. K., Feldmann, F., Gary, J. M., Jordan, R., Bannister, R., Cronin, J., Patel, N. R., Klena, J. D., Nichol, S. T., Cihlar, T., Zaki, S. R., Feldmann, H., Spiropoulou, C. F., & de Wit, E. (2019). Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge. Science Translational Medicine, 11(494), eaau9242. https://doi.org/10.1126/scitranslmed.aau9242
   PubMed Web of Science ®Google Scholar
• Mackie, P. (2003). The classification of viruses infecting the respiratory tract. Paediatric Respiratory Reviews, 4(2), 84–90. https://doi.org/10.1016/S1526-0542(03)00031-9
   PubMedGoogle Scholar
• Mahase, E. (2020). Coronavirus: Covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. British Medical Journal Publishing Group.
   Google Scholar
• Menéndez-Arias, L., Álvarez, M., & Pacheco, B. (2014). Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: Mechanism of action and resistance. Current Opinion in Virology, 8, 1–9. https://doi.org/10.1016/j.coviro.2014.04.005
   PubMed Web of Science ®Google Scholar
• Mercorelli, B., Palù, G., & Loregian, A. (2018). Drug repurposing for viral infectious diseases: How far are we? Trends in Microbiology, 26(10), 865–876. https://doi.org/10.1016/j.tim.2018.04.004
   PubMed Web of Science ®Google Scholar
• Morra, M. E., Van Thanh, L., Kamel, M. G., Ghazy, A. A., Altibi, A. M. A., Dat, L. M., Thy, T. N. X., Vuong, N. L., Mostafa, M. R., Ahmed, S. I., Elabd, S. S., Fathima, S., Le Huy Vu, T., Omrani, A. S., Memish, Z. A., Hirayama, K., & Huy, N. T. (2018). Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta‐analysis. Reviews in Medical Virology, 28(3), e1977. https://doi.org/10.1002/rmv.1977
   PubMed Web of Science ®Google Scholar
• Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–7. https://doi.org/10.1080/07391102.2020.1752802
   PubMed Web of Science ®Google Scholar
• Novel, C. P. E. R. E. (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liuxingbingxue Zazhi, 41, 145.
   Google Scholar
• Oh, M.-D., Park, W. B., Choe, P. G., Choi, S.-J., Kim, J.-I., Chae, J., Park, S. S., Kim, E.-C., Oh, H. S., Kim, E. J., Nam, E. Y., Na, S. H., Kim, D. K., Lee, S.-M., Song, K.-H., Bang, J. H., Kim, E. S., Kim, H. B., Park, S. W., & Kim, N. J. (2016). Viral load kinetics of MERS coronavirus infection. The New England Journal of Medicine, 375(13), 1303–1305. https://doi.org/10.1056/NEJMc1511695
   PubMed Web of Science ®Google Scholar
• Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R. L., & Yang, L. (2020). Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology, 200370.
   Web of Science ®Google Scholar
• Pant, S., Singh, M., Ravichandiran, V., Murty, U., & Srivastava, H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/10.1080/07391102.2020.1757510
   PubMed Web of Science ®Google Scholar
• Paules, C. I., Marston, H. D., & Fauci, A. S. (2020). Coronavirus infections—more than just the common cold. Jama, 323(8), 707–708. https://doi.org/10.1001/jama.2020.0757
   PubMed Web of Science ®Google Scholar
• Peeri, N. C., Shrestha, N., Rahman, M. S., Zaki, R., Tan, Z., Bibi, S., Baghbanzadeh, M., Aghamohammadi, N., Zhang, W., & Haque, U. (2020). The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned? International Journal of Epidemiology, 1–10. https://doi.org/10.1093/ije/dyaa033
   Google Scholar
• Plotkin, S., Robinson, J. M., Cunningham, G., Iqbal, R., & Larsen, S. (2017). The complexity and cost of vaccine manufacturing - An overview. Vaccine, 35(33), 4064–4071. https://doi.org/10.1016/j.vaccine.2017.06.003
   PubMed Web of Science ®Google Scholar
• Prompetchara, E., Ketloy, C., & Palaga, T. (2020). Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology, 38(1), 1–9. https://doi.org/10.12932/AP-200220-0772
   PubMed Web of Science ®Google Scholar
• Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, 102433. https://doi.org/10.1016/j.jaut.2020.102433
   PubMed Web of Science ®Google Scholar
• Sarma, P., Sekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., & Dhibar, D. P. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1753580
   PubMed Web of Science ®Google Scholar
• Senanayake, S. L. (2020). Drug repurposing strategies for COVID-19. Future Science, 2(2), 1–3.
   Google Scholar
• Senathilake, K., Samarakoon, S., & Tennekoon, K. (2020). Virtual screening of inhibitors against spike glycoprotein of 2019 novel corona virus: A drug repurposing approach. Preprints, 1–15. https://doi.org/10.20944/preprints202003.0042.v1
   Google Scholar
• Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., Bannister, R., Park, Y., Babusis, D., Clarke, M. O., Mackman, R. L., Spahn, J. E., Palmiotti, C. A., Siegel, D., Ray, A. S., … Baric, R. S. (2017). Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Science Translational Medicine, 9(396), eaal3653. https://doi.org/10.1126/scitranslmed.aal3653
   PubMed Web of Science ®Google Scholar
• Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., Spahn, J. E., Bauer, L., Sellers, S., Porter, D., Feng, J. Y., Cihlar, T., Jordan, R., Denison, M. R., & Baric, R. S. (2020). Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature Communications, 11(1), 14. https://doi.org/10.1038/s41467-019-13940-6
   PubMed Web of Science ®Google Scholar
• Siegel, D., Hui, H. C., Doerffler, E., Clarke, M. O., Chun, K., Zhang, L., Neville, S., Carra, E., Lew, W., & Ross, B. (2017). Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo [2, 1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses. ACS Publications.
   Google Scholar
• Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019). From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 11(1), 59. https://doi.org/10.3390/v11010059
   PubMed Web of Science ®Google Scholar
• Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2019). Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses, 11(4), 326. https://doi.org/10.3390/v11040326
   PubMed Web of Science ®Google Scholar
• Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical Medicine & International Health: TM & IH, 25(3), 278–280. https://doi.org/10.1111/tmi.13383
   PubMed Web of Science ®Google Scholar
• Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/10.1038/s41422-020-0282-0
   PubMed Web of Science ®Google Scholar
• Wang, Y., Wang, Y., Chen, Y., & Qin, Q. (2020). Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. Journal of Medical Virology, 92(6), 568–576. https://doi.org/10.1002/jmv.25748
   PubMed Web of Science ®Google Scholar
• Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., Larson, N., Strickley, R., Wells, J., Stuthman, K. S., Van Tongeren, S. A., Garza, N. L., Donnelly, G., Shurtleff, A. C., Retterer, C. J., … Bavari, S. (2016). Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature, 531(7594), 381–385. https://doi.org/10.1038/nature17180
   PubMed Web of Science ®Google Scholar
• Woo, P. C., Huang, Y., Lau, S. K., & Yuen, K.-Y. (2010). Coronavirus genomics and bioinformatics analysis. Viruses, 2(8), 1804–1820. https://doi.org/10.3390/v2081803
   PubMed Web of Science ®Google Scholar
• Woo, P. C., Lau, S. K., Li, K. S., Poon, R. W., Wong, B. H., Tsoi, H-w., Yip, B. C., Huang, Y., Chan, K-h., & Yuen, K-y. (2006). Molecular diversity of coronaviruses in bats. Virology, 351(1), 180–187. https://doi.org/10.1016/j.virol.2006.02.041
   PubMed Web of Science ®Google Scholar
• Xiong, R., Zhang, L., Li, S., Sun, Y., Ding, M., Wang, Y., Zhao, Y., Wu, Y., Shang, W., & Jiang, X. (2020). Novel and potent inhibitors targeting DHODH, a rate-limiting enzyme in de novo pyrimidine biosynthesis, are broad-spectrum antiviral against RNA viruses including newly emerged coronavirus SARS-CoV-2. bioRxiv. https://doi.org/10.1101/2020.03.11.983056
   Google Scholar
• Xu, J., Shi, P.-Y., Li, H., & Zhou, J. (2020). Broad spectrum antiviral agent niclosamide and its therapeutic potential. ACS Infectious Diseases, 6(5), 909–915. https://doi.org/10.1021/acsinfecdis.0c00052
   PubMed Web of Science ®Google Scholar
• Xu, M., Lee, E. M., Wen, Z., Cheng, Y., Huang, W.-K., Qian, X., Tcw, J., Kouznetsova, J., Ogden, S. C., Hammack, C., Jacob, F., Nguyen, H. N., Itkin, M., Hanna, C., Shinn, P., Allen, C., Michael, S. G., Simeonov, A., Huang, W., … Tang, H. (2016). Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nature Medicine, 22(10), 1101–1107. https://doi.org/10.1038/nm.4184
   PubMed Web of Science ®Google Scholar
• Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., Tai, Y., Bai, C., Gao, T., Song, J., Xia, P., Dong, J., Zhao, J., & Wang, F.-S. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine, 8(4), 420–422. https://doi.org/10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Yao, Y., Bao, L., Deng, W., Xu, L., Li, F., Lv, Q., Yu, P., Chen, T., Xu, Y., Zhu, H., Yuan, J., Gu, S., Wei, Q., Chen, H., Yuen, K.-Y., & Qin, C. (2014). An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. The Journal of Infectious Diseases, 209(2), 236–242. https://doi.org/10.1093/infdis/jit590
   PubMed Web of Science ®Google Scholar
• Zhu, Z., Zhong, C., Zhang, K., Dong, C., Peng, H., Xu, T., Wang, A., Guo, Z., & Zhang, Y. (2020). Epidemic trend of corona virus disease 2019 (COVID-19) in mainland China. Zhonghua yu Fang yi Xue za Zhi [Chinese Journal of Preventive Medicine], 54, E022. https://doi.org/10.3760/cma.j.cn112150-20200222-00163
   PubMedGoogle Scholar
• Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S., & Yuen, K.-Y. (2016). Coronaviruses - drug discovery and therapeutic options. Nature Reviews Drug Discovery, 15(5), 327–347. https://doi.org/10.1038/nrd.2015.37
   PubMed Web of Science ®Google Scholar